id,agency_id,docket_id,title,document_type,subtype,posted_date,posted_year,posted_month,comment_start_date,comment_end_date,last_modified,fr_doc_num,open_for_comment,withdrawn,object_id
FDA-2011-E-0246-0003,FDA,FDA-2011-E-0246,FDA\CDER to United States Patent and Trademark Office - Letter,Other,LET-Letter,2011-06-09T04:00:00Z,2011,6,2011-06-09T04:00:00Z,,2011-06-09T12:59:41Z,,0,0,0900006480e42948
FDA-2011-E-0246-0002,FDA,FDA-2011-E-0246,U.S. Patent and Trademark Office - Letter,Other,LET-Letter,2011-04-05T04:00:00Z,2011,4,2011-04-05T04:00:00Z,,2013-07-27T23:49:16Z,,0,0,0900006480c1bf1c
FDA-2011-E-0246-0001,FDA,FDA-2011-E-0246,Takeda Pharmaceutical Company LTD (Foley & Lardner LLP) - Patent Extension Application,Other,APP-Application,2011-04-05T04:00:00Z,2011,4,2011-04-05T04:00:00Z,,2013-07-27T23:49:16Z,,0,0,0900006480c1bf1a